We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
West Pharmaceutical Services Inc | NYSE:WST | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
1.52 | 0.42% | 366.54 | 369.17 | 364.07 | 366.59 | 332,533 | 21:15:06 |
|
|
|
|
|
|
|
þ
|
ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
Items
|
|
1 to 3.
|
Not required; see Item 4 below.
|
|
|
4.
|
The following are furnished for the Plan:
|
|
(a) The West Contract Manufacturing Savings and Retirement Plan is subject to the Employee Retirement Income Security Act of 1974 (“ERISA”), as amended, and is, therefore, filing Plan financial statements and schedules prepared in accordance with the financial reporting requirements of ERISA.
|
|
(b) A written consent of the accountant.
|
|
Page
|
|
|
FINANCIAL STATEMENTS:
|
|
|
|
SUPPLEMENTAL INFORMATION*:
|
|
|
|
|
|
|
2017
|
2016
|
||||
Assets:
|
|
|
||||
|
|
|
||||
Investments:
|
|
|
||||
Investments at fair value (Note D)
|
$
|
4,384,317
|
|
$
|
3,619,007
|
|
Plan interest in Master Trust (Note C)
|
133,260
|
|
104,648
|
|
||
Total investments
|
4,517,577
|
|
3,723,655
|
|
||
|
|
|
||||
Receivables:
|
|
|
||||
Employer contributions
|
51,696
|
|
1,958
|
|
||
Notes receivable from participants
|
251,670
|
|
261,501
|
|
||
Total receivables
|
303,366
|
|
263,459
|
|
||
|
|
|
||||
Total assets
|
4,820,943
|
|
3,987,114
|
|
||
|
|
|
||||
Liabilities:
|
|
|
||||
Excess contributions payable
|
4,625
|
|
11,300
|
|
||
|
|
|
||||
Net assets available for benefits
|
$
|
4,816,318
|
|
$
|
3,975,814
|
|
|
2017
|
2016
|
||||
Additions:
|
|
|
||||
Investment income:
|
|
|
||||
Interest and dividend income
|
$
|
223,420
|
|
$
|
110,948
|
|
Net appreciation in fair value of investments
|
398,723
|
|
181,571
|
|
||
Plan interest in Master Trust net investment income
|
19,218
|
|
29,616
|
|
||
Net investment income
|
641,361
|
|
322,135
|
|
||
|
|
|
||||
Interest income on notes receivable from participants
|
11,000
|
|
10,508
|
|
||
|
|
|
||||
Contributions:
|
|
|
||||
Employer
|
193,673
|
|
129,374
|
|
||
Participant
|
242,750
|
|
201,743
|
|
||
Total contributions
|
436,423
|
|
331,117
|
|
||
|
|
|
||||
Total additions
|
1,088,784
|
|
663,760
|
|
||
|
|
|
||||
Deductions:
|
|
|
||||
Benefits paid
|
242,586
|
|
180,143
|
|
||
Plan expenses
|
5,694
|
|
5,376
|
|
||
Total deductions
|
248,280
|
|
185,519
|
|
||
|
|
|
||||
Net increase
|
840,504
|
|
478,241
|
|
||
|
|
|
||||
Net assets available for plan benefits:
|
|
|
||||
Beginning of the year
|
3,975,814
|
|
3,497,573
|
|
||
End of the year
|
$
|
4,816,318
|
|
$
|
3,975,814
|
|
|
2017
|
2016
|
||||
Dividends
|
$
|
265,993
|
|
$
|
284,996
|
|
Net appreciation in fair value of common stock
|
6,670,091
|
|
14,345,703
|
|
||
Net investment income
|
6,936,084
|
|
14,630,699
|
|
||
Net transfers
|
(8,143,191
|
)
|
(5,932,457
|
)
|
||
(Decrease) increase in net assets
|
(1,207,107
|
)
|
8,698,242
|
|
||
Net assets:
|
|
|
||||
Beginning of year
|
45,767,757
|
|
37,069,515
|
|
||
End of year
|
$
|
44,560,650
|
|
$
|
45,767,757
|
|
Level 1
:
|
Unadjusted quoted prices in active markets for identical assets or liabilities.
|
Level 2
:
|
Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.
|
Level 3
:
|
Unobservable inputs that reflect the reporting entity’s own assumptions.
|
|
|
|
|
Balance at
|
||||||||
|
Basis of Fair Value Measurements
|
December 31,
|
||||||||||
|
Level 1
|
Level 2
|
Level 3
|
2017
|
||||||||
Mutual funds
|
$
|
4,384,317
|
|
$
|
—
|
|
$
|
—
|
|
$
|
4,384,317
|
|
Investments at fair value
|
$
|
4,384,317
|
|
$
|
—
|
|
$
|
—
|
|
$
|
4,384,317
|
|
|
|
|
|
Balance at
|
||||||||
|
Basis of Fair Value Measurements
|
December 31,
|
||||||||||
|
Level 1
|
Level 2
|
Level 3
|
2016
|
||||||||
Mutual funds
|
$
|
3,619,007
|
|
$
|
—
|
|
$
|
—
|
|
$
|
3,619,007
|
|
Investments at fair value
|
$
|
3,619,007
|
|
$
|
—
|
|
$
|
—
|
|
$
|
3,619,007
|
|
|
PLAN EIN: 86-0640193
|
|
|
|
||
|
PLAN NUMBER: 001
|
|
|
|
||
|
|
|
|
|
||
(a)
|
(b) Identity of issue, borrower, lessor, or similar party
|
(c) Description of investment including maturity date, rate of interest, collateral, par, or maturity value
|
(d) Cost
|
(e) Current Value
|
||
*
|
American Funds EuroPacific Growth Fund
|
Mutual Fund
|
**
|
$
|
328,473
|
|
*
|
Vanguard Diversified Equity Fund
|
Mutual Fund
|
**
|
1,339,369
|
|
|
*
|
Vanguard Institutional Target Retirement 2015 Fund
|
Mutual Fund
|
**
|
13,711
|
|
|
*
|
Vanguard Institutional Target Retirement 2020 Fund
|
Mutual Fund
|
**
|
603,371
|
|
|
*
|
Vanguard Institutional Target Retirement 2025 Fund
|
Mutual Fund
|
**
|
101,136
|
|
|
*
|
Vanguard Institutional Target Retirement 2030 Fund
|
Mutual Fund
|
**
|
118,882
|
|
|
*
|
Vanguard Institutional Target Retirement 2035 Fund
|
Mutual Fund
|
**
|
88,375
|
|
|
*
|
Vanguard Institutional Target Retirement 2040 Fund
|
Mutual Fund
|
**
|
60,539
|
|
|
*
|
Vanguard Institutional Target Retirement 2045 Fund
|
Mutual Fund
|
**
|
92,381
|
|
|
*
|
Vanguard Institutional Target Retirement 2050 Fund
|
Mutual Fund
|
**
|
9,396
|
|
|
*
|
Vanguard Institutional Target Retirement 2055 Fund
|
Mutual Fund
|
**
|
2,140
|
|
|
*
|
Vanguard Institutional Target Retirement Income Fund
|
Mutual Fund
|
**
|
266,453
|
|
|
*
|
Vanguard Prime Money Market Fund
|
Mutual Fund
|
**
|
182,841
|
|
|
*
|
Vanguard Total Bond Market Index Fund Institutional Shares
|
Mutual Fund
|
**
|
348,765
|
|
|
*
|
Vanguard Total Stock Market Index Fund Institutional Shares
|
Mutual Fund
|
**
|
828,485
|
|
|
*
|
West Stock Fund
|
Master Trust
|
**
|
133,260
|
|
|
*
|
Participant Loans
|
4.25% - 5.25%
|
$0
|
251,670
|
|
|
|
|
|
|
$
|
4,769,247
|
|
|
|
|
|
|
||
*
|
Party-in-interest
|
|
|
|
||
**
|
Cost has been omitted, as investment is participant-directed.
|
|
|
Exhibit
Number
|
|
Description
|
23.1
|
|
1 Year West Pharmaceutical Serv... Chart |
1 Month West Pharmaceutical Serv... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions